July 31, 2014: Drs. David Scheinberg, Co-Chair of the Pharmacology PhD Program at Weill Cornell; Lucy Kappel, Regeneron; Barry Kappel, VP at CFRX; & Jimmy Rotolo, CFRX, ring the opening bell at NASDAQ! Lucy, Weill Cornell Immunology Program PhD, Barry & Jimmy, Pharmacology Program PhDs! CFRX is now listed on NASDAQ.
Mar 22, 2018